You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

radiotherapy

Showing 1 - 25 of 394
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • CapeOX + cetuximab
  • +2 more
  • (no location specified)
Sep 12, 2023

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • (no location specified)
Mar 17, 2023

Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy

Recruiting
  • Urothelial Carcinoma
  • Radiotherapy
  • +2 more
  • Beijing, China
  • +2 more
Nov 2, 2023

Urothelial Carcinoma Trial (Disitamab Vedotin, radiotherapy)

Not yet recruiting
  • Urothelial Carcinoma
  • Disitamab Vedotin
  • radiotherapy
  • (no location specified)
Jun 20, 2023

Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),

Active, not recruiting
  • Rectal Cancer
  • Locally Advanced
  • Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
  • Radiotherapy
  • Tunis, Tunisia
    Amel Mezlini
May 19, 2023

Nasopharyngeal Carcinoma Trial in Shanghai (Radiotherapy, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Jan 7, 2023

NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage III
  • radiotherapy
  • +3 more
  • (no location specified)
Sep 10, 2023

High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Surufatinib, Sintilimab, Radiotherapy)

Recruiting
  • High-Risk Localized Soft Tissue Sarcoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 20, 2023

Rhabdomyosarcoma, Child Trial (Realgar-Indigo Naturalis Formulation, Radiotherapy)

Not yet recruiting
  • Rhabdomyosarcoma, Child
  • Realgar-Indigo Naturalis Formulation
  • Radiotherapy
  • (no location specified)
Jan 31, 2023

Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)

Not yet recruiting
  • Basal Cell Carcinoma
  • Radiotherapy; Complications
  • Radiotherapy
  • +2 more
  • (no location specified)
Sep 30, 2022

Soft Tissue Sarcoma, High Risk of Recurrence, Anlotinib Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Soft Tissue Sarcoma
  • +3 more
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Nov 1, 2022

High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)

Recruiting
  • High-Risk Localized Soft Tissue Sarcoma
  • Pegylated Liposomal Doxorubicin
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2023

Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue Trial in Saint Louis (ADI PEG20, Ifosfamide, Radiotherapy)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • ADI PEG20
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 2, 2023

Hepatocellular Carcinoma Trial in Beijing (Sintilimab, Lenvatinib, radiotherapy)

Recruiting
  • Hepatocellular Carcinoma
  • Beijing, Beijing, China
    Beijing Tsinghua Changgung Hospital
Jan 5, 2023

Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)

Active, not recruiting
  • Metastatic
  • +4 more
  • Radiotherapy
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 6, 2023

Non Small Cell Lung Cancer Trial in Changsha (radiotherapy, Chemotherapy + immunotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • radiotherapy
  • Chemotherapy + immunotherapy
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Oct 17, 2022

Recurrent Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)

Not yet recruiting
  • Recurrent Rectal Cancer
  • PD-1 antibody
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 17, 2022

Extensive-stage Small-cell Lung Cancer Trial in Sydney, Brisbane, Melbourne (Radiotherapy, Chemotherapy)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Sydney, New South Wales, Australia
  • +6 more
Mar 21, 2023

Thyroid Cancer Trial in Chengdu (Tislelizumab, Anlotinib, Radiotherapy)

Recruiting
  • Thyroid Cancer
  • Chengdu, Sichuan, China
    Xingchen Peng
Dec 17, 2022

Solitary Plasmacytoma Trial in Beijing (radiotherapy, Bortezomib Injection, Lenalidomide)

Recruiting
  • Solitary Plasmacytoma
  • radiotherapy
  • +3 more
  • Beijing, China
    Peking Union Medical College Hospital
Apr 22, 2022

Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)

Active, not recruiting
  • Laryngeal Cancer Stage II
  • +3 more
  • Amsterdam, Netherlands
    The Netherlands Cancer Institute
Sep 27, 2022

Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography Trial in Umeå, Jönköping (stereotactic body

Recruiting
  • Prostate Cancer Metastatic
  • +2 more
  • stereotactic body radiotherapy
  • +2 more
  • Umeå, Umea, Sweden
  • +1 more
May 19, 2022

Cervical Cancer Trial in Shanghai (adjuvant concurrent chemoradiotherapy, radiotherapy)

Recruiting
  • Cervical Cancer
  • adjuvant concurrent chemoradiotherapy
  • radiotherapy
  • Shanghai, Shanghai, China
  • +1 more
Sep 14, 2022

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Astrocytoma, Grade III Trial in San Antonio, Zuerich (Debio 0123,

Not yet recruiting
  • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
  • Astrocytoma, Grade III
  • Debio 0123
  • +2 more
  • San Antonio, Texas
  • +1 more
Mar 9, 2023

HNSCC Trial in Saint-Mandé (Cisplatin, radiotherapy)

Recruiting
  • HNSCC
  • Saint-Mandé, France
    Hôpital Bégin
Mar 10, 2022